Skip to main content

Walleye Capital LLC

SEC CIK
0001758720
Latest filing
Aug 3, 2026

BMRN holding history

Biomarin Pharmaceutical Inc in every 13F filed by Walleye Capital LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BMRN overviewAll 13F holders of BMRNFull Q2 2026 holdings

Shares (Q2 2026)
288,233
Value
$16.5M
% of portfolio
0.1%
Quarters held
20
Since Q2 2021
Holdings of BMRN by Walleye Capital LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026288,233$16.5M0.1%−76,013−20.9%ReducedHolders
Q1 2026364,246$20.6M0.1%+141,779+63.7%AddedHolders
Q4 2025222,467$13.2M0.1%+150,655+209.8%AddedHolders
Q3 202571,812$3.89M<0.1%+71,746+108,706.1%AddedHolders
Q2 202566$3.63K<0.1%−32,705−99.8%ReducedHolders
Q1 202532,771$2.32M<0.1%+4,699+16.7%AddedHolders
Q4 202428,072$1.85M<0.1%−127,370−81.9%ReducedHolders
Q3 2024155,442$10.9M0.1%+117,119+305.6%AddedHolders
Q2 202438,323$3.16M<0.1%+3,639+10.5%AddedHolders
Q1 202434,684$3.03M<0.1%+22,111+175.9%AddedHolders
Q4 202312,573$1.21M<0.1%+7,572+151.4%AddedHolders
Q3 20235,001$442.5K<0.1%−43,638−89.7%ReducedHolders
Q2 202348,639$4.22M0.1%−88,633−64.6%ReducedHolders
Q1 2023137,272$13.3M0.3%+71,798+109.7%AddedHolders
Q4 202265,474$6.78M0.1%−27,272−29.4%ReducedHolders
Q3 202292,746$7.86M0.2%+52,496+130.4%AddedHolders
Q2 202240,250$3.34M0.1%−75,399−65.2%ReducedHolders
Q1 2022115,649$8.92M0.3%+104,154+906.1%AddedHolders
Q4 202111,495$1.02M<0.1%+11,495NewHolders
Q3 20210$00.0%−3,560−100.0%Sold outHolders
Q2 20213,560$297.0K<0.1%+3,560NewHolders